Endovascular treatment for posterior epistaxis: should it still be considered a last-resort option? A literature review

• by Hector R. Martinez, Daniel F. Aguilera-Maldonado, Andrea Paola Sanchez-Cantu, Patricia Maria Orviz-Ortiz, Oscar I. Paz-Sanchez, Nerea Martin del Campo, Carlos Cuilty-Siller, Karla Santos-Santillan, Jorge Arechavaleta Santos, Oscar Gutierrez Trevino, Beatriz Elena Perez-Martinez, Jose A. Figueroa-Sanchez

• April 7, 2026

Nasal kaposiform hemangioendothelioma: a rare disease in a rare location—a review article with a case report

• by Feras Alkholaiwi, Ji Yun Choi

• May 13, 2026

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

• by Kerri Miller

• April 16, 2026

• 3 min

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

• by Kathryn Wighton

• January 27, 2026

• 3 min